• Citer

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus.

par Van Der Meeren, Olivier;Peterson, James T;Dionne, Marc;Beasley, Richard;Ebeling, Peter R;Ferguson, Murdo;Nissen, Michael MD;Rheault, Paul;Simpson, Richard RW;De Ridder, Marc ;Crasta, Priya Diana;Miller, Jacqueline M;Trofa, Andrew AF
Référence Human Vaccines and Immunotherapeutics, page (1-7)
Publication Publié, 2016-04

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Objective: Patients with diabetes mellitus are at increased risk for hepatitis B virus (HBV) infection and its complications. HBV vaccination is recommended for adults with diabetes in the United States and other countries. However, few studies have assessed safety and immunogenicity of hepatitis B vaccine in such patients. We assessed the safety and immunogenicity of recombinant hepatitis B vaccine in subjects with and without diabetes mellitus.